Stay updated on Pembrolizumab in HCC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in HCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in HCC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The record for a Phase 2 pembrolizumab study in advanced hepatocellular carcinoma is displayed, including its eligibility criteria, study design, outcome measures, results, and study documents.
    Difference
    42%
    Check dated 2026-11-08T15:34:40.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The displayed site revision changed from v3.7.2 to v3.8.0 while the study page continued to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T16:38:45.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    A sitewide NIH notice announces a transition-related update to terminology, including the use of “Super Intelligence” in place of “Artificial Intelligence.”
    Difference
    1%
    Check dated 2026-10-25T15:55:44.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-18T20:47:52.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.0 to v3.7.1 while the page continued to show a 403 error.
    Difference
    0.2%
    Check dated 2026-10-11T20:48:51.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error screen with minimal navigation, replacing the previous study details for the NCT03163992 trial; the content sections and links related to the trial have been removed or hidden.
    Difference
    17%
    Check dated 2026-09-20T20:14:51.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in HCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in HCC Clinical Trial page.